You have 9 free searches left this month | for more free features.

Bladder infusion

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Chapel Hill, Durham (pembrolizumab, gemcitabine and cisplatin)

Active, not recruiting
  • Bladder Cancer
  • pembrolizumab, gemcitabine and cisplatin
  • Chapel Hill, North Carolina
  • +1 more
Oct 11, 2022

Stem Cell Infusion Trial in Hanoi (Autologous bone marrow mononuclear cell transplantation)

Completed
  • Stem Cell Infusion
  • Autologous bone marrow mononuclear cell transplantation
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Jul 20, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Bladder Carcinoma Trial in France (Avelumab, GC)

Terminated
  • Bladder Carcinoma
  • Besançon, France
  • +12 more
Apr 26, 2022

Invasive Bladder Cancer Trial in Charleston (Cystectomy, Lidocaine, Saline)

Completed
  • Invasive Bladder Cancer
  • Cystectomy
  • +2 more
  • Charleston, West Virginia
    Urology center of charleston
Mar 7, 2022

Bladder Cancer Trial in Manchester (sample collection, Sample Collection)

Completed
  • Bladder Cancer
  • sample collection
  • Sample Collection
  • Manchester, Gtr Manchester, United Kingdom
    The Christie NHS Foundation Trust
Aug 6, 2021

Advanced Solid Tumor Trial in Kansas City (CPX-POM)

Recruiting
  • Advanced Solid Tumor
  • Kansas City, Kansas
    University of Kansas Medical Center
Jun 24, 2022

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

Completed
  • Bladder Cancer
  • induction cisplatin
  • +13 more
  • Atlanta, Georgia
  • +10 more
May 23, 2022

Urothelial Carcinoma Trial in Milan (Sacituzumab govitecan)

Recruiting
  • Urothelial Carcinoma
  • Sacituzumab govitecan
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 7, 2022

Bladder Cancer Trial in Belgium, France, Spain (BCG, Atezolizumab)

Recruiting
  • Bladder Cancer
  • Haine Saint Paul, Belgium
  • +37 more
May 24, 2022

Bladder Cancer, High-Risk Cancer, Tremelimumab Trial in Vancouver (Tremelimumab)

Recruiting
  • Bladder Cancer
  • +4 more
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Nov 3, 2021

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)

Recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  • Multifocal Motor Neuropathy (MMN)
  • Nagoya, Aichi, Japan
  • +16 more
Feb 2, 2023

Urinary Bladder Tumors, Immunotherapy Trial in Shanghai (Camrelizumab)

Recruiting
  • Urinary Bladder Neoplasms
  • Immunotherapy
  • Shanghai, Shanghai, China
  • +3 more
Oct 9, 2021

Interstitial Cystitis (IC)-Like Findings With Hydrodistension

Terminated
  • Interstitial Cystitis
    • Saint Louis, Missouri
      St. Mary's Health Center
    Jan 11, 2022

    Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

    Recruiting
    • Invasive Bladder Cancer
    • Madrid, Spain
      Hospital 12 de Octubre
    Feb 8, 2022

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023

    Perinatal Arterial Ischemic Stroke Trial in Orlando (Autologous Cord Blood Infusion)

    Suspended
    • Perinatal Arterial Ischemic Stroke
    • Autologous Cord Blood Infusion
    • Orlando, Florida
      Florida Hospital for Children
    Mar 16, 2022

    Bladder Carcinoma, Post-operative Pain Trial in Los Angeles (Placebo, Questionnaire Administration, Ropivacaine Hydrochloride)

    Withdrawn
    • Bladder Carcinoma
    • Post-operative Pain
    • Placebo
    • +2 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Apr 13, 2019

    Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal

    Active, not recruiting
    • Localized Renal Pelvis and Ureter Urothelial Carcinoma
    • +10 more
    • Biospecimen Collection
    • +9 more
    • Birmingham, Alabama
    • +922 more
    Jan 28, 2023

    Stress Urinary Incontinence Trial in New Taipei City (Urodynamic investigations before and after a trans-obturator tape

    Recruiting
    • Stress Urinary Incontinence
    • Urodynamic investigations before and after a trans-obturator tape protocol.
    • New Taipei City, Taiwan
      Department of Obstetrics and Gynecology
    Feb 23, 2022

    Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution

    Active, not recruiting
    • Oncology
    • +5 more
    • MRx0518
    • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
    • Kansas City, Kansas
    • +4 more
    Jul 5, 2022

    Bladder Cancer, Biliary Tract Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Rare Tumors Trial

    Active, not recruiting
    • Bladder Cancer, Biliary Tract Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Rare Tumors
    • Trastuzumab deruxtecan
    • Duarte, California
    • +75 more
    Jul 15, 2022

    Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)

    Active, not recruiting
    • Bladder Cancer
    • Atlanta, Georgia
    • +12 more
    Mar 28, 2022

    Catheter Related Complication Trial in Ankara (Tramadol, Dexmedetomidine, control)

    Completed
    • Catheter Related Complication
    • Ankara, Turkey
      Diskapi Training and Research Hospital
    Nov 8, 2021